Jeanne-Marie Lecomte

This inventor holds 56 USPTO granted patents and 9 published patent applications, plus 15 CIPO patents and 18 EPO patents, primarily in Pharmaceutical Chemistry (CPC class A61K). Top assignees: Bioprojet, Societe Civile Bioprojet, National Institute of Health and Medical Research. Active years: 1983-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeanne-Marie Lecomte. Retrieved from https://idiyas.com/inventor/jeanne-marie-lecomte

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 56 (Patent Applications = 9)

% Patents Active = 85.7

CIPO Patents = 15 (Patent Applications = 9)

EPO Patents = 18 (Patent Applications = 30)

Average Co-Inventor Count = 5.7

ph-index = 10

Forward Citations = 620(Granted Patents)

Forward Citations (Not Self Cited) = 586(Dec 10, 2025)

Inventors with similar research interests:

Location History:

75003 Paris, FR (1986 - 1988)
Paris, FR (1983 - 2022)

Company Filing History:

Societe Civile Bioprojet

patents

10 out of 1,853

National Institute of Health and Medical Research

Societe Civile Bioproject

Sun Pharma Advanced Research Company Limited

patents

8. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

9. 1 out of 1

Societe Civile Brioprojet

Universite De Caen - Esplanade De La Faix

patent

12. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1983-2026

Loading Chart...

Areas of Expertise:

Dopamine D3 Agonists

Histamine Receptor Ligands

S1P1 Receptor Agonists

Enkephalinase Inhibitors

Amino Acid Derivatives

Pharmaceutical Compositions

Benzimidazole Derivatives

Imidazole Compounds

Therapeutic Applications

Dicarboxylic Acid Derivatives

Antidepressant Combinations

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582648 - Method for treating central nervous system disorders using dopamine D3 partial agonists (2026-03-24),

2. 12134608 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2024-11-05),

3. 11306069 - Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands (2022-04-19),

4. 11179329 - Therapeutical use of H3-ligands (2021-11-23),

5. 11078183 - Tetrahydrate of H3 ligand, its process of preparation and pharmaceutical compositions comprising the same (2021-08-03),

6. 10952987 - Combination of adrenalin with an antidepressant for use in the treatment of shocks (2021-03-23),

7. 9439853 - Form of administration of enkephalinase inhibitor (2016-09-13),

8. 9266867 - Piperidinyl monocarboxylic acids as S1P1 receptor agonists (2016-02-23),

9. 9255101 - 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands (2016-02-09),

10. 9242959 - (Aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications (2016-01-26),

11. 9029357 - Benzazole derivatives as histamine H4 receptor ligands (2015-05-12),

12. 8809539 - Dicarboxylic acid derivatives as S1P1 receptor agonists (2014-08-19),

13. 8802678 - [object Object] (2014-08-12),

14. 8802664 - Benzazole derivatives as histamine H4 receptor ligands (2014-08-12),

15. 8486947 - [object Object] (2013-07-16),

Title: Jeanne-Marie Lecomte: A Visionary in the World of Inventions

Introduction:

Jeanne-Marie Lecomte, a dedicated inventor based in Paris, FR, is a true visionary in the world of inventions. With a remarkable passion for creating a better future through technology, he has made significant contributions to the field of innovation.

Latest Patents:

With an impressive portfolio of 54 patents, Jeanne-Marie Lecomte continues to push the boundaries of innovation. His latest patents include groundbreaking inventions like 'Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands' and 'Therapeutical use of H3-ligands', showcasing his expertise in pharmaceutical research and development.

Career Highlights:

Throughout his career, Jeanne-Marie Lecomte has worked with renowned companies such as Bioprojet and Societe Civile Bioprojet, where he has played a key role in developing cutting-edge technologies and novel solutions. His innovative spirit and meticulous approach to invention have set him apart as a leader in the industry.

Collaborations:

Collaboration plays a vital role in the world of inventions, and Jeanne-Marie Lecomte has had the privilege of working with esteemed colleagues like Jean-Charles Schwartz and Denis Danvy. Together, they have shared insights, expertise, and a common goal of driving innovation forward.

Conclusion:

In conclusion, Jeanne-Marie Lecomte's dedication to innovation and his relentless pursuit of creating groundbreaking solutions have cemented his reputation as a true visionary in the world of inventions. His passion for making a positive impact through technology continues to inspire inventors and creators worldwide, shaping a brighter future for generations to come.

Profile summary based on public USPTO records.